Stock listing
NASDAQ:OCAT Ocata Therapeutics Inc Stock
Follow Ocata Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:OCAT
$8.47 USD
Close on Feb 9, 2016 · No longer trades
- Lowest – highest close
- $1.00 – $700.00 USDSince Feb 17, 2005 · lowest Jul 28, 2008 · highest Feb 18, 2005
Delisted NASDAQ:OCAT no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:OCAT
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Ocata Therapeutics Inc on 6ix
- Decks
- 3 decks · latest Feb 9, 2015
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| BIO CEO Presentation (February 2015) | Conference | 32 slides | Feb 9, 2015 |
| IPO Roadshow (December 2014) | IPO roadshow | 32 slides | Dec 19, 2014 |
| Advanced Cell Technology — Investor Presentation (July 2007) | Investor deck | 55 slides | Jul 2, 2007 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Robert Langer Other companies: Seer, Inc. (Director · Since at least Dec 3, 2020); Lyra Therapeutics, Inc. (David H. Koch Institute Professor, Massachusetts Institute of Technology · Since at least Apr 30, 2020); Korro Bio, Inc. (Director · Oct 2, 2019 – Aug 17, 2022 · Past); Moderna, Inc. (Director · Dec 7, 2018 – May 6, 2024 · Past); Rubius Therapeutics Inc (Director · Jul 17, 2018 – Oct 14, 2019 · Past); Kala Bio, Inc. (Director · Jul 19, 2017 – Jun 12, 2018 · Past); BIND Therapeutics Inc (Director · Sep 19, 2013 – Jun 21, 2016 · Past) | Director · Oct 4, 2011 – Feb 10, 2016 · Past |
Log in to ask 6ix AI your own questions about Ocata Therapeutics Inc.